ישראל - עברית - Ministry of Health

novartis pharma services ag - zoledronic acid 4 mg/vial - powder for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

novartis pharma services ag - zoledronic acid 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

novartis israel ltd - zoledronic acid - תמיסה לאינפוזיה - zoledronic acid 5 mg / 100 ml - zoledronic acid - zoledronic acid - treatment of paget's disease of the bone. treatment of osteoporosis : - in post-menopausal women - in men at increased risk of fracture including those with a recent low-trauma hip fracture.treatment and prevention of glucocorticoid-induced osteoporosis.prevention of postmenopausal osteoporosis in women for whom bisphosphonate therapy is indicated.

ישראל - עברית - Ministry of Health

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - alendronic acid as monohydrate - טבליה - alendronic acid as monohydrate 10 mg - alendronic acid

ישראל - עברית - Ministry of Health

truemed ltd, israel - risedronic acid as sodium - טבליות מצופות פילם - risedronic acid as sodium 150 mg - risedronic acid

ישראל - עברית - Ministry of Health

novartis israel ltd - zoledronic acid - תמיסה לאינפוזיה - zoledronic acid 5 mg / 100 ml - zoledronic acid

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - alendronic acid as trihydrate - טבליה תוססת - alendronic acid as trihydrate 70 mg - alendronic acid

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - zoledronic acid as monohydrate - תמיסה לאינפוזיה - zoledronic acid as monohydrate 4 mg / 100 ml - zoledronic acid